Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05004012 · ClinicalTrials.gov registry record · NA

Magnetically Controlled Capsule Endoscopy Feasibility Study in Gastric Motility

A NA study of Gastroparesis and Dyspepsia, sponsored by University of California, Los Angeles.

Active
Registry status
NA
Development phase
17
Enrollment target
1
Study location

NCT05004012 is a NA study of Gastroparesis and Dyspepsia that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 17 participants, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05004012, a NA study of Gastroparesis and Dyspepsia, is active but no longer recruiting, sponsored by University of California, Los Angeles.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
17 participants
Enrollment target
1
Study location

Study Summary

This is a feasibility study to assess the utility of magnetically controlled capsule endoscopy in the evaluation of gastroparesis and functional dyspepsia

Conditions Studied

Interventions

  • DEVICE Magnetically Controlled Capsule Endoscopy

Study Locations (1)

California

  • University of California Los Angeles - Los Angeles

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2021-12-01
Est. Completion 2024-08
Phase NA

What the Registry Record Tells You About NCT05004012

The ClinicalTrials.gov registry entry for NCT05004012 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (94% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Gastroparesis appearing as the primary indexed condition, and to 1 intervention - of which Magnetically Controlled Capsule Endoscopy is the first listed.

NCT05004012 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05004012 about?

NCT05004012 is a clinical study titled "Magnetically Controlled Capsule Endoscopy Feasibility Study in Gastric Motility". This is a feasibility study to assess the utility of magnetically controlled capsule endoscopy in the evaluation of gastroparesis and functional dyspepsia

What is the current status of trial NCT05004012?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 17 participants. The study started on 2021-12-01. Estimated completion is 2024-08.

What conditions does trial NCT05004012 study?

This clinical trial studies the following conditions: Gastroparesis, Dyspepsia.

What interventions are being tested in trial NCT05004012?

The interventions under investigation include: Magnetically Controlled Capsule Endoscopy (DEVICE).

Who is sponsoring clinical trial NCT05004012?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05004012 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastroparesis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.